NCT05734495 2026-05-28Pirtobrutinib and Venetoclax in Waldenström MacroglobulinemiaDana-Farber Cancer InstitutePhase 2 Active not recruiting46 enrolled
NCT05024045 2026-03-03Study of Oral LOXO-338 in Patients With Advanced Blood CancersEli Lilly and CompanyPhase 1 Active not recruiting316 enrolled